Literature DB >> 19478829

New pancreatic carcinoma model for studying oncolytic adenoviruses in the permissive Syrian hamster.

J F Spencer1, J E Sagartz, W S M Wold, K Toth.   

Abstract

Syrian hamster is a practical animal model for studying the systemic effects of oncolytic vectors derived from adenovirus serotype 5 (Ad5). Ad5 replicates well in Syrian hamster tissues, and Syrian hamster cell lines are available that are known to support Ad5 replication. In this study, we established four new Syrian hamster cell lines from transplantable pancreatic, renal, hepatic and lung tumors. The pancreatic cell line (SHPC6) and the renal cell line were highly permissive for Ad5 replication. The SHPC6 cell line formed disseminated intraperitoneal tumors when cells were injected into the peritoneal cavity. INGN 007, an oncolytic Ad5-based vector, completely reversed the growth of disseminated intraperitoneal SHPC6 tumor nodules following intraperitoneal injection of the vector, leading to 100% survival of the treated animals. SHPC6 cells also formed subcutaneous tumors, whose growth was suppressed by INGN 007 following intratumoral injection. INGN 007 replicated in both the intraperitoneal and subcutaneous SHPC6 tumors. Following intraperitoneal injection, INGN 007 did not replicate in the livers of hamsters with intraperitoneal SHPC6 tumors, and was not hepatotoxic. These studies suggest that the SHPC6 cell line may be useful as a model for disseminated pancreatic cancer, and that INGN 007 may be a safe and effective vector to treat these tumors.

Entities:  

Mesh:

Year:  2009        PMID: 19478829      PMCID: PMC3433944          DOI: 10.1038/cgt.2009.36

Source DB:  PubMed          Journal:  Cancer Gene Ther        ISSN: 0929-1903            Impact factor:   5.987


  49 in total

Review 1.  Adenoviral gene therapy for pancreatic adenocarcinoma.

Authors:  Pedro J Ramírez; Selwyn M Vickers
Journal:  Curr Surg       Date:  2004 Jul-Aug

2.  Infection of mouse liver by human adenovirus type 5.

Authors:  S J Duncan; F C Gordon; D W Gregory; J L McPhie; R Postlethwaite; R White; H N Willcox
Journal:  J Gen Virol       Date:  1978-07       Impact factor: 3.891

3.  Use of the Syrian hamster as an animal model for oncolytic adenovirus vectors.

Authors:  Maria A Thomas; Jacqueline F Spencer; William S M Wold
Journal:  Methods Mol Med       Date:  2007

4.  Two types of peritoneal dissemination of pancreatic cancer cells in a hamster model.

Authors:  S Yamamura; M Onda; E Uchida
Journal:  Nihon Ika Daigaku Zasshi       Date:  1999-08

5.  Adenoviral delivery of TIMP1 or TIMP2 can modify the invasive behavior of pancreatic cancer and can have a significant antitumor effect in vivo.

Authors:  A S Rigg; N R Lemoine
Journal:  Cancer Gene Ther       Date:  2001-11       Impact factor: 5.987

6.  Oncolytic adenovirus that overproduces ADP and replicates selectively in tumors due to hTERT promoter-regulated E4 gene expression.

Authors:  M Kuppuswamy; J F Spencer; K Doronin; A E Tollefson; W S M Wold; K Toth
Journal:  Gene Ther       Date:  2005-11       Impact factor: 5.250

7.  Short and long term dissemination of deletion mutants of adenovirus in permissive (cotton rat) and non-permissive (mouse) species.

Authors:  W Oualikene; P Gonin; M Eloit
Journal:  J Gen Virol       Date:  1994-10       Impact factor: 3.891

8.  Replication-competent adenovirus-mediated suicide gene therapy with radiation in a preclinical model of pancreatic cancer.

Authors:  Svend O Freytag; Kenneth N Barton; Stephen L Brown; Vinod Narra; Yingshu Zhang; Don Tyson; Colleen Nall; Mei Lu; Munther Ajlouni; Benjamin Movsas; Jae Ho Kim
Journal:  Mol Ther       Date:  2007-06-12       Impact factor: 11.454

9.  An oncolytic adenovirus vector combining enhanced cell-to-cell spreading, mediated by the ADP cytolytic protein, with selective replication in cancer cells with deregulated wnt signaling.

Authors:  Karoly Toth; Hakim Djeha; Baoling Ying; Ann E Tollefson; Mohan Kuppuswamy; Konstantin Doronin; Peter Krajcsi; Kai Lipinski; Christopher J Wrighton; William S M Wold
Journal:  Cancer Res       Date:  2004-05-15       Impact factor: 12.701

Review 10.  Intravascular adenoviral agents in cancer patients: lessons from clinical trials.

Authors:  Tony Reid; Robert Warren; David Kirn
Journal:  Cancer Gene Ther       Date:  2002-12       Impact factor: 5.987

View more
  19 in total

Review 1.  Oncolytic virotherapy for pancreatic cancer.

Authors:  Sonia Wennier; Shoudong Li; Grant McFadden
Journal:  Expert Rev Mol Med       Date:  2011-05-18       Impact factor: 5.600

2.  A fully replication-competent adenovirus vector with enhanced oncolytic properties.

Authors:  K Toth; M Kuppuswamy; E V Shashkova; J F Spencer; W S M Wold
Journal:  Cancer Gene Ther       Date:  2010-07-02       Impact factor: 5.987

3.  Pathology in Permissive Syrian Hamsters after Infection with Species C Human Adenovirus (HAdV-C) Is the Result of Virus Replication: HAdV-C6 Replicates More and Causes More Pathology than HAdV-C5.

Authors:  Ann E Tollefson; Baoling Ying; Jacqueline F Spencer; John E Sagartz; William S M Wold; Karoly Toth
Journal:  J Virol       Date:  2017-04-28       Impact factor: 5.103

4.  Establishment of a mammary carcinoma cell line from Syrian hamsters treated with N-methyl-N-nitrosourea.

Authors:  Malari A Coburn; Sabrina Brueggemann; Shilpa Bhatia; Bing Cheng; Benjamin D L Li; Xiao-Lin Li; Natalia Luraguiz; Yulia Y Maxuitenko; Elysse A Orchard; Songlin Zhang; Mariam A Stoff-Khalili; J Michael Mathis; Heather E Kleiner-Hancock
Journal:  Cancer Lett       Date:  2011-08-17       Impact factor: 8.679

5.  Pre-existing immunity and passive immunity to adenovirus 5 prevents toxicity caused by an oncolytic adenovirus vector in the Syrian hamster model.

Authors:  Debanjan Dhar; Jacqueline F Spencer; Karoly Toth; William S M Wold
Journal:  Mol Ther       Date:  2009-07-14       Impact factor: 11.454

6.  Virotherapy using a novel chimeric oncolytic adenovirus prolongs survival in a human pancreatic cancer xenograft model.

Authors:  Quyen D Chu; Guang Sun; Matt Pope; Natalia Luraguiz; David T Curiel; Roger Kim; Benjamin D L Li; J Michael Mathis
Journal:  Surgery       Date:  2012-07-31       Impact factor: 3.982

7.  The effects of radiation on antitumor efficacy of an oncolytic adenovirus vector in the Syrian hamster model.

Authors:  B A Young; J F Spencer; B Ying; K Toth; W S M Wold
Journal:  Cancer Gene Ther       Date:  2013-08-09       Impact factor: 5.987

8.  Validation of assays to monitor immune responses in the Syrian golden hamster (Mesocricetus auratus).

Authors:  Marko Zivcec; David Safronetz; Elaine Haddock; Heinz Feldmann; Hideki Ebihara
Journal:  J Immunol Methods       Date:  2011-02-17       Impact factor: 2.303

9.  Increasing the efficacy of oncolytic adenovirus vectors.

Authors:  Karoly Toth; William S M Wold
Journal:  Viruses       Date:  2010-08-27       Impact factor: 5.818

10.  STAT2 Knockout Syrian Hamsters Support Enhanced Replication and Pathogenicity of Human Adenovirus, Revealing an Important Role of Type I Interferon Response in Viral Control.

Authors:  Karoly Toth; Sang R Lee; Baoling Ying; Jacqueline F Spencer; Ann E Tollefson; John E Sagartz; Il-Keun Kong; Zhongde Wang; William S M Wold
Journal:  PLoS Pathog       Date:  2015-08-20       Impact factor: 6.823

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.